Virtual reality offers new hope for comfort in final months

NCT ID NCT07545928

Not yet recruiting Symptom relief Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an interactive virtual reality (VR) program can help reduce pain, anxiety, and fatigue in 20 hospitalized palliative care patients. Participants use a VR headset with sensors to interact with a calming natural environment for 10 minutes daily over 14 days. The main goal is to see if the approach is feasible and well-tolerated, not yet to prove it works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Interactive virtual reality program (ZenctuaryVR+) delivered via head-mounted display with biosensors
What this could lead to: If successful, this could point toward a non-drug way to help palliative care patients manage pain, anxiety, and fatigue, improving their quality of life.
What could go wrong: This is a very small pilot study (20 people) with no control group, so results may not apply broadly. The VR device may cause discomfort or not be tolerated by all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder depressive disorder Mental Fatigue Pain, Intractable

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY DEPRESSION DISORDERS FATIGUE, MENTAL PALLIATIVE CARE PSYCHOLOGICAL DISTRESS REFRACTORY PAIN

Contacts and locations

Locations

Hôpitaux Universitaires de Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.